Bellicum Pharmaceuticals, Inc. (BLCM) Social Stream
BELLICUM PHARMACEUTICALS INC (BLCM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BELLICUM PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-17 | 1 | $5 | $5 | $5 | $0.3 | 1566.67% |
| NA | 1 | $NA | $NA | $NA | $0.3 | NA% |
Price Target Last Issued February 17, 2023
The Trend in the Analyst Price Target
BLCM's average price target has moved down $0 over the prior 12 months.
Over the past 26 weeks, BLCM's average upside potential has been 335.72%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-16 | 1 | 5 | 5 | 5 | 1.45 | 244.83% |
| 2022-11-15 | 1 | 5 | 5 | 5 | 1.07 | 367.29% |
| 2023-02-17 | 1 | 5 | 5 | 5 | 1.01 | 395.05% |
BLCM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 35 weeks, BLCM's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, BELLICUM PHARMACEUTICALS INC's number of analysts covering the stock is higher than practically none of them.
- In the context of all US stocks, BELLICUM PHARMACEUTICALS INC's variance in analysts' estimates is lower than nearly 100% of them.
- In terms of how BELLICUM PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 95.15% of that group.
- In terms of how BELLICUM PHARMACEUTICALS INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 7.12% of that group.
Stocks similar to BELLICUM PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SLRX, ARAV, and ABUS.
View All Top Stocks by Price Target
Is BLCM a Buy, Hold or Sell? See the POWR Ratings now!